ND Expert Sean Kassen: Statement on first FDA-approved treatment for Niemann-Pick Type C disease
Today, the FDA announced the first approved treatment for Niemann-Pick Type C (NPC) disease: an oral medication named Miplyffa (arimoclomol). Sean Kassen, director of the Ara Parseghian Medical Research Fund at the University of Notre Dame, said this represents the beginning of a new and hopeful era for NPC families.
“It has been almost 30 years to the day since Michael, Marcia and Christa Parseghian were diagnosed with Niemann-Pick Type C disease, eventually taking their young lives. Since that time the Parseghian family and so many other families, researchers and volunteers have worked tirelessly to advance our understanding of NPC and bring treatments to those affected by this devastating disease. Today marks a momentous occasion with the FDA approval of Miplyffa and the start of a new era with the first official medication for the treatment of NPC disease. We will continue to fight for NPC families until this disease is eradicated,” Kassen said.
The APMRF is a non-profit organization dedicated to finding a treatment or cure for Niemann-Pick Type C disease. The organization is named in honor of Ara Parseghian, the much beloved and well-known Notre Dame football coach, and was founded by Mike and Cindy Parseghian, whose three children — Michael, Marcia and Christa — were diagnosed with NPC in 1994.
Latest ND NewsWire
- Gen. Martin Dempsey to speak at Notre Dame Forum event on ‘Hope, Global Stability and the Role of the United States’Gen. Martin Dempsey, the retired 18th chairman of the Joint Chiefs of Staff, will join University President Rev. Robert A. Dowd, C.S.C., for a fireside chat at 4 p.m. Friday (Oct. 10), as part of the 2025-26 Notre Dame Forum. The discussion, titled “Hope, Global Stability and the Role of the United States,” is part of the exploration of this year’s Notre Dame Forum theme, “Cultivating Hope.” It will take place in Rooms 215/216 of McKenna Hall and will also be livestreamed. The event is free and open to the public.
- University of Notre Dame joins the Global Coalition of Ukrainian StudiesThe University of Notre Dame has joined the Global Coalition of Ukrainian Studies after signing a memorandum of cooperation, formalized Sept. 24, at the Ukrainian Institute of America in New York City. Notre Dame joined four other American institutions that were also publicly welcomed to the coalition at this event: Arizona State University, Columbia University, Manor College and the Shevchenko Scientific Society.
- One year later, Inauguration Build a ‘dream come true’ for Habitat familiesOne year later, work on Inauguration Build 2024 is complete, offering shelter and so much more to five local families.
- Alumni Association and YoungND honor 2025 Domer DozenThe Notre Dame Alumni Association announced its 2025 Domer Dozen cohort, honoring 12 graduates ages 32 and younger for excellence in their contributions in learning, service, faith and work — the core pillars of the association’s mission.
- Faculty receive prestigious early career awards from National Science FoundationDuring the 2024-25 academic year, four researchers in the University of Notre Dame’s Colleges of Engineering and Science received early-career awards from the National Science Foundation.
- Notre Dame School of Architecture poised for global leadership through historic investmentThe $150 million gift represents an unprecedented commitment in the 160-year history of American architectural education. In recognition of this landmark gift, the school will be renamed the Matthew and Joyce Walsh School of Architecture at Notre Dame.
